STUDY OF CLINICAL AND NEUROHUMORAL PARAMETERS IN PATIENTS WITH THYROTOXICOSIS WITH COMORRIDITY WITH CHRONIC HEART FAILURE
Authors/Creators
- 1. Republican Specialized Scientific-practical Medical Center Of Endocrinology named after Acad.Yo.H. Turakulov Tashkent, Uzbekistan
- 2. Doctor of Medical Sciences, professor, Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation Tashkent, Uzbekistan
- 3. Doctor of Medical Sciences, Republican Specialized Scientific-practical Medical Center Of Endocrinology
Description
The clinical and neurohumoral features of thyrotoxicosis comorbidity in patients with chronic heart failure were studied. The patients with FC II, medium-high levels of BNP prevailed, while in patients with FC III, a predominance of high levels of BNP was noted. Intermediate and high levels of BNP predominated in patients with FC II, while high levels of BNP predominated in patients with FC III. Based on the data obtained, a program was developed to determine the prognosis of the course of the disease in patients with thyrotoxicosis with comorbidity of CHF. At the same time, indicators of the clinical course of morbidity, hormone levels and BNP indicators. Thus, in patients with thyrotoxicosis, comorbidity with CHF II with FC II, medium-high levels of BNP prevailed, while in patients with III FC there was a predominance of high levels of BNP, which correlated with the severity of the course of the disease and indicators of FV LV.